Chromosomal changes in high- and low-invasive mouse lung adenocarcinoma cell strains derived from early passage mouse lung adenocarcinoma cell strains

Toxicology and Applied Pharmacology

Volumn 233, Issue 1, 2008, Pages 81-91

  Sargent, Linda M ^a   Ensell, Mang X ^b   Ostvold, Anne Carine ^c   Baldwin, Kimberly T ^a   Kashon, Michael L ^a   Lowry, David T ^a   Senft, Jamie R ^a   Jefferson, Amy M ^a   Johnson, Robert C ^d   Li, Zhi ^e   Tyson, Frederick L ^f   Reynolds, Steven H ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c UNIVERSITY OF OSLO   (Norway)

^d Spectral Genomics Inc   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Amplification; CGH array; Chromosome 1; Lung adenocarcinoma; Mouse model

Indexed keywords

CYCLOOXYGENASE 2; GENE PRODUCT; PROTEIN DYRK3; PROTEIN NUCKS; TRANSLIN; TUBULIN ALPHA4; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER MODEL; CHROMOSOME 1; CHROMOSOME 15; CHROMOSOME 8; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; COMPARATIVE GENOMIC HYBRIDIZATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION PROFILING; GENE MAPPING; LUNG ADENOCARCINOMA; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SPECTRAL KARYOTYPING; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL MOVEMENT; CHROMOSOME ABERRATIONS; KARYOTYPING; LUNG NEOPLASMS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; SPECIES SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 55649122520     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.01.031     Document Type: Article

References (55)

1. Agochiya M., Brunton V.G., Owens D.W., Parkinson E.K., Paraskeva C., Keith W.N., and Frame M.C. Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells. Oncogene 18 (1999) 5646-5653
2. American Cancer Society. ACS 2006 Cancer Statistics (2006). http://www.cancer.org/docroot/cri/content/cri_2_4_1x_what_are_the_key_statistics_for_lung_cancer_26.asp http://www.cancer.org/docroot/cri/content/cri_2_4_1x_what_are_the_key_statistics_for_lung_cancer_26.asp
3. Balsara B.R., and Testa J.R. Chromosomal imbalances in human lung cancer. Oncogene 21 (2002) 6877-6883
4. Bauer A.K., Dwyer-Nield L.D., Keil K., Koski K., and Malkinson A.M. Butylated hydroxytoluene (BHT) induction of pulmonary inflammation: a role in tumor promotion. Exp. Lung Res. 27 (2001) 197-216
5. Bauer A.K., Malkinson A.M., and Kleeberger S.R. Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities. Am. J. Physiol., Lung Cell. Mol. Physiol. 287 (2004) L685-L703
6. Beer D.G., Kardia S.L., Huang C.C., Giordano T.J., Levin A.M., Misek D.E., Lin L., Chen G., Gharib T.G., Thomas D.G., Lizyness M.L., Kuick R., Hayasaka S., Taylor J.M., Iannettoni M.D., Orringer M.B., and Hanash S. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nature medicine 8 (2002) 816-824
7. Boengler K., Gres P., Cabestrero A., Ruiz-Meana M., Garcia-Dorado D., Heusch G., and Schulz R. Prevention of the ischemia-induced decrease in mitochondrial Tom20 content by ischemic preconditioning. J. Mol. Cell. Cardiol. 41 (2006) 426-430
8. Chennathukuzhi V., Stein J.M., Abel T., Donlon S., Yang S., Miller J.P., Allman D.M., Simmons R.A., and Hecht N.B. Mice deficient for testis-brain RNA-binding protein exhibit a coordinate loss of TRAX, reduced fertility, altered gene expression in the brain, and behavioral changes. Mol. Cell. Biol. 23 (2003) 6419-6434
9. Cho Y.S., Iguchi N., Yang J., Handel M.A., and Hecht N.B. Meiotic messenger RNA and noncoding RNA targets of the RNA-binding protein translin (TSN) in mouse testis. Biol. Reprod. 73 (2005) 840-847
10. Cohen S., Jacob E., and Manor H. Effects of single-stranded DNA binding proteins on primer extension by telomerase. Biochim. Biophys. Acta 1679 (2004) 129-140
11. Driscoll K.E., Carter J.M., Iype P.T., Kumari H.L., Crosby L.L., Aardema M.J., Isfort R.J., Cody D., Chestnut M.H., Burns J.L., et al. Establishment of immortalized alveolar type II epithelial cell lines from adult rats. In Vitro Cell. Dev. Biol., Anim. 31 (1995) 516-527
12. Fabjani G., Tong D., Wolf A., Roka S., Leodolter S., Hoecker P., Fischer M.B., Jakesz R., and Zeillinger R. HMGA2 is associated with invasiveness but not a suitable marker for the detection of circulating tumor cells in breast cancer. Oncol. Rep. 14 (2005) 737-741
13. Festing M.F., Lin L., Devereux T.R., Gao F., Yang A., Anna C.H., White C.M., Malkinson A.M., and You M. At least four loci and gender are associated with susceptibility to the chemical induction of lung adenomas in A/J × BALB/c mice. Genomics 53 (1998) 129-136
14. Fijneman R.J., de Vries S.S., Jansen R.C., and Demant P. Complex interactions of new quantitative trait loci, Sluc1, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse. Nat. Genet. 14 (1996) 465-467
15. Foley J.F., Anderson M.W., Stoner G.D., Gaul B.W., Hardisty J.F., and Maronpot R.R. Proliferative lesions of the mouse lung: progression studies in strain A mice. Exp. Lung Res. 17 (1991) 157-168
16. Goeze A., Schluns K., Wolf G., Thasler Z., Petersen S., and Petersen I. Chromosomal imbalances of primary and metastatic lung adenocarcinomas. J. Pathol. 196 (2002) 8-16
17. Grundt K., Haga I.V., Aleporou-Marinou V., Drosos Y., Wanvik B., and Ostvold A.C. Characterisation of the NUCKS gene on human chromosome 1q32.1 and the presence of a homologous gene in different species. Biochem. Biophys. Res. Commun. 323 (2004) 796-801
18. Haston C.K., and Travis E.L. Murine susceptibility to radiation-induced pulmonary fibrosis is influenced by a genetic factor implicated in susceptibility to bleomycin-induced pulmonary fibrosis. Cancer Res. 57 (1997) 5286-5291
19. Hemminki K., Lonnstedt I., Vaittinen P., and Lichtenstein P. Estimation of genetic and environmental components in colorectal and lung cancer and melanoma. Genet. Epidemiol. 20 (2001) 107-116
20. Hu Z., Miao X., Ma H., Wang X., Tan W., Wei Q., Lin D., and Shen H. A common polymorphism in the 3′UTR of cyclooxygenase 2/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population. Lung Cancer 48 (2005) 11-17
21. Jacob E., Pucshansky L., Zeruya E., Baran N., and Manor H. The human protein translin specifically binds single-stranded microsatellite repeats, d(GT)n, and G-strand telomeric repeats, d(TTAGGG)n: a study of the binding parameters. J. Mol. Biol. 344 (2004) 939-950
22. Jemal A., Travis W.D., Tarone R.E., Travis L., and Devesa S.S. Lung cancer rates convergence in young men and women in the United States: analysis by birth cohort and histologic type. Int. J. Cancer 105 (2003) 101-107
23. Kubokura H., Tenjin T., Akiyama H., Koizumi K., Nishimura H., Yamamoto M., and Tanaka S. Relations of the c-myc gene and chromosome 8 in non-small cell lung cancer: analysis by fluorescence in situ hybridization. Ann. Thorac. Cardiovasc. Surg. 7 (2001) 197-203
24. Levin N.A., Brzoska P.M., Warnock M.L., Gray J.W., and Christman M.F. Identification of novel regions of altered DNA copy number in small cell lung tumors. Genes Chromosomes Cancer 13 (1995) 175-185
25. Li Y.H., and Zhu C. A modified Boyden chamber assay for tumor cell transendothelial migration in vitro. Clin. Exp. Metastasis 17 (1999) 423-429
26. Li K., Zhao S., Karur V., and Wojchowski D.M. DYRK3 activation, engagement of protein kinase A/cAMP response element-binding protein, and modulation of progenitor cell survival. J. Biol. Chem. 277 (2002) 47052-47060
27. Lu Y.J., Dong X.Y., Shipley J., Zhang R.G., and Cheng S.J. Chromosome 3 imbalances are the most frequent aberration found in non-small cell lung carcinoma. Lung Cancer 23 (1999) 61-66
28. Malkinson A.M. Genetic studies on lung tumor susceptibility and histogenesis in mice. Environ. Health Perspect. 93 (1991) 149-159
29. Malkinson A.M. Primary lung tumors in mice: an experimentally manipulable model of human adenocarcinoma. Cancer Res. 52 (1992) 2670s-2676s
30. Malkinson A.M., Radcliffe R.A., and Bauer A.K. Quantitative trait locus mapping of susceptibilities to butylated hydroxytoluene-induced lung tumor promotion and pulmonary inflammation in CXB mice. Carcinogenesis 23 (2002) 411-417
31. McCulloch C., and Searle S. Generalized, Linear and Mixed Models (2001), Wiley, New York
32. Multani A.S., Ozen M., Sen S., Mandal A.K., Price J.E., Fan D., Radinsky R., Ali-Osman F., Von Eschenbach A.C., Fidler I.J., and Pathak S. Amplification of telomeric DNA directly correlates with metastatic potential of human and murine cancers of various histological origin. Int. J. Oncol. 15 (1999) 423-429
33. Naylor T.L., Greshock J., Wang Y., Colligon T., Yu Q.C., Clemmer V., Zaks T.Z., and Weber B.L. High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization. Breast Cancer Res. 7 (2005) R1186-R1198
34. Niki T., Kohno T., Iba S., Moriya Y., Takahashi Y., Saito M., Maeshima A., Yamada T., Matsuno Y., Fukayama M., Yokota J., and Hirohashi S. Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas. Am. J. Pathol. 160 (2002) 1129-1141
35. O'Donovan K.J., and Baraban J.M. Major Egr3 isoforms are generated via alternate translation start sites and differ in their abilities to activate transcription. Mol. Cell. Biol. 19 (1999) 4711-4718
36. Ostvold A.C., Holtlund J., and Laland S.G. A novel, highly phosphorylated protein, of the high-mobility group type, present in a variety of proliferating and non-proliferating mammalian cells. Eur. J. Biochem. 153 (1985) 469-475
37. Ostvold A.C., Norum J.H., Mathiesen S., Wanvik B., Sefland I., and Grundt K. Molecular cloning of a mammalian nuclear phosphoprotein NUCKS, which serves as a substrate for Cdk1 in vivo. Eur. J. Biochem. 268 (2001) 2430-2440
38. Oue N., Aung P.P., Mitani Y., Kuniyasu H., Nakayama H., and Yasui W. Genes involved in invasion and metastasis of gastric cancer identified by array-based hybridization and serial analysis of gene expression. Oncology 69 Suppl 1 (2005) 17-22
39. Park J.M., Choi J.E., Chae M.H., Lee W.K., Cha S.I., Son J.W., Kim C.H., Kam S., Kang Y.M., Jung T.H., and Park J.Y. Relationship between cyclooxygenase 8473T > C polymorphism and the risk of lung cancer: a case-control study. BMC cancer 6 (2006) 70
40. Pettus J.A., Cowley B.C., Maxwell T., Milash B., Stephenson R.A., Rohr L.R., Hoff C., and Brothman A.R. Multiple abnormalities detected by dye reversal genomic microarrays in prostate cancer: a much greater sensitivity than conventional cytogenetics. Cancer Genet. Cytogenet. 154 (2004) 110-118
41. Pinlaor S., Tada-Oikawa S., Hiraku Y., Pinlaor P., Ma N., Sithithaworn P., and Kawanish S. Opisthorchis viverrini antigen induces the expression of Toll-like receptor 2 in macrophage Raw cell line. Int. J. Parasitol. 35 (2005) 591-596
42. Sargent L., Dragan Y.P., Babcock K., Wiley J., Klaunig J., and Pitot H.C. Cytogenetic analysis of three rat liver epithelial cell lines (WBneo, WBHa-ras, and WBrasIIa) and correlation of an early chromosomal alteration with insulin-like growth factor II expression. Cancer Res. 56 (1996) 2992-2997
43. Sargent L.M., Zhou X., Keck C.L., Sanderson N.D., Zimonjic D.B., Popescu N.C., and Thorgeirsson S.S. Nonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-Myc and transforming growth factor-alpha in the liver. Am. J. Pathol. 154 (1999) 1047-1055
44. Sargent L.M., Nelson M.A., Lowry D.T., Senft J.R., Jefferson A.M., Ariza M.E., and Reynolds S.H. Detection of three novel translocations and specific common chromosomal break sites in malignant melanoma by spectral karyotyping. Genes Chromosomes Cancer 32 (2001) 18-25
45. Sargent L.M., Senft J.R., Lowry D.T., Jefferson A.M., Tyson F.L., Malkinson A.M., Coleman A.E., and Reynolds S.H. Specific chromosomal aberrations in mouse lung adenocarcinoma cell lines detected by spectral karyotyping: a comparison with human lung adenocarcinoma. Cancer Res. 62 (2002) 1152-1157
46. Schrock E., du Manoir S., Veldman T., Schoell B., Wienberg J., Ferguson-Smith M.A., Ning Y., Ledbetter D.H., Bar-Am I., Soenksen D., Garini Y., and Ried T. Multicolor spectral karyotyping of human chromosomes. Science 273 (1996) 494-497
47. Sy S.M., Wong N., Lee T.W., Tse G., Mok T.S., Fan B., Pang E., Johnson P.J., and Yim A. Distinct patterns of genetic alterations in adenocarcinoma and squamous cell carcinoma of the lung. Eur. J. Cancer 40 (2004) 1082-1094
48. Thompson H.G., Harris J.W., Wold B.J., Quake S.R., and Brody J.P. Identification and confirmation of a module of coexpressed genes. Genome Res. 12 (2002) 1517-1522
49. Travis W.D., Lubin J., Ries L., and Devesa S. United States lung carcinoma incidence trends: declining for most histologic types among males, increasing among females. Cancer 77 (1996) 2464-2470
50. Tripodis N., Hart A.A., Fijneman R.J., and Demant P. Complexity of lung cancer modifiers: mapping of thirty genes and twenty-five interactions in half of the mouse genome. J. Natl. Cancer Inst. 93 (2001) 1484-1491
51. Verhagen P.C., Zhu X.L., Rohr L.R., Cannon-Albright L.A., Tavtigian S.V., Skolnick M.H., and Brothman A.R. Microdissection, DOP-PCR, and comparative genomic hybridization of paraffin-embedded familial prostate cancers. Cancer Genet. Cytogenet. 122 (2000) 43-48
52. Viscardi R.M., Ullsperger S., and Resau J.H. Reproducible isolation of type II pneumocytes from fetal and adult rat lung using nycodenz density gradients. Exp. Lung Res. 18 (1992) 225-245
53. Wu M.C., Sundaresan M., Sundaresan V., and Rabbitts P. Genome wide search for genetic damage in p53 transgenic mouse lung tumours reveals consistent loss of chromosome 4. Eur. J. Cancer 33 (1997) 1677-1684
54. Yao R., Rioux N., Castonguay A., and You M. Inhibition of COX-2 and induction of apoptosis: two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis. Exp. Lung Res. 26 (2000) 731-742
55. Zhao X., Weir B.A., LaFramboise T., Lin M., Beroukhim R., Garraway L., Beheshti J., Lee J.C., Naoki K., Richards W.G., Sugarbaker D., Chen F., Rubin M.A., Janne P.A., Girard L., Minna J., Christiani D., Li C., Sellers W.R., and Meyerson M. Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis. Cancer Res. 65 (2005) 5561-5570